| Partnership Health Center Inc | |
|
2200 Mullan Rd Ste A Missoula MT 59808-2059 | |
| (406) 258-4949 | |
| (406) 258-4732 |
| Full Name | Partnership Health Center Inc |
|---|---|
| Speciality | Clinic/center - Federally Qualified Health Center (fqhc) |
| Location | 2200 Mullan Rd Ste A, Missoula, Montana |
| Authorized Official Name and Position | Bryan Chalmers (CFO) |
| Authorized Official Contact | 4062584445 |
| Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
| Mailing Address | Practice Location Address |
|---|---|
| Partnership Health Center Inc 401 Railroad St W Missoula MT 59802-4178 Ph: (406) 258-4122 | Partnership Health Center Inc 2200 Mullan Rd Ste A Missoula MT 59808-2059 Ph: (406) 258-4949 |
| NPI Number | 1013623248 |
|---|---|
| Provider Enumeration Date | 01/31/2023 |
| Last Update Date | 01/31/2023 |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013623248 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261QF0400X | Clinic/center - Federally Qualified Health Center (fqhc) | (* (Not Available)) | Primary |
News Archive
Ligand Pharmaceuticals Incorporated today announced that its partner GlaxoSmithKline has been granted priority review from the US Food and Drug Administration for the supplemental new drug application for Promacta to treat thrombocytopenia in adult patients with chronic hepatitis C virus (HCV) infection.
A new editorial released this week offers clarity and structure on confusing drug and alcohol addiction terminology for prescribers, users and regulators. "Through a glass darkly: can we improve clarity about mechanism and aims of medications in drug and alcohol treatments?" is published in the Journal of Psychopharmacology, the official journal of the British Association for Psychopharmacology, published by SAGE.
Taking a new approach to the treatment and prevention of Alzheimer's disease, a research team led by investigators at the Mayo Clinic campus in Florida has shown that druglike compounds can speed up destruction of the amyloid beta (A-beta) proteins that form plaque in the brains of patients with the disorder.
Takeda Pharmaceutical Company Limited ("Takeda") today announced that a Marketing Authorisation Application (MAA) has been submitted to The European Medicines Agency (EMA) for vedolizumab, an investigational, gut-selective humanized monoclonal antibody for the treatment of adults with moderately to severely active ulcerative colitis (UC) and Crohn's disease (CD), the two most common types of inflammatory bowel disease (IBD).
› Verified 2 days ago
Tms Revitalizes Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 2809 Great Northern Loop, Ste 410, Missoula, MT 59808 Phone: 406-493-1344 Fax: 406-830-3127 | |
Sentinel Health Pllc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 601 High Park Way, Missoula, MT 59803 Phone: 406-272-6151 | |
Biome Group Health, Pllc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 2831 Fort Missoula Rd. Bldg. 2, Ste. 203, Missoula, MT 59804 Phone: 480-628-3002 | |
Western Montana Clinic Pc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 2835 Fort Missoula Rd Bldg 3, Missoula, MT 59804 Phone: 406-721-5600 | |
Greater Good Health Pc, Inc. Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 2230 N Reserve St Ste 110, Missoula, MT 59808 Phone: 310-658-3775 | |
Cardiopulmonary Associates Of Montana, Pllc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 601 W Spruce St, Suite A, Missoula, MT 59802 Phone: 406-329-2945 |